BioSpace News Archive

Avinger, Inc., a commercial-stage medical device company marketing the first-ever image-guided, catheter-based system for the diagnosis and treatment of Peripheral Artery Disease, announced that its executive team will participate in the H.C. Wainwright Bioconnect 2021 Conference taking place virtually January 11-14, 2021.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Chief Financial Officer Sung Lee is leaving the Company to pursue a new opportunity overseas. Mr. Lee’s last day of employment will be February 1, 2021. “Sung has contributed significantly to Sangamo’s evolution, helping us build a strong cash position to advance proprietary medicines for patients in need as we begin a year w

vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes and inflammatory diseases, today announced that it is participating in the LifeSci Partners 10 th Annual Healthcare Corporate Access Event held virtually from January 11-14 2021. Company management will be conducting one-on-one virtual meetings during the week of the conference

Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it has engaged Independent Trading Group (ITG), Inc. (“ ITG ”) to provide market-making services to the Company in accordance with TSX Venture Exchange (“ TSXV ”) policies. ITG will trade the Company’s common shares (the “ Common Shares ”) on the TSXV and other marketplaces, as applicable, with the

Nektar Therapeutics’ (Nasdaq: NKTR) President and Chief Executive Officer, Howard Robin , is scheduled to present at the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference on Monday, January 11, 2021 at 11:50 a.m. Pacific Time . The presentation and Q&A session will be accessible via a Webcast through a link poste

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company’s management will present at the J.P. Morgan 39 th Annual Healthcare Conference on Thursday, January 14, 2021, at 9:10 a.m. ET, and will be available for virtual investor meetings. A live webcast of the presentation can be access

Walgreens Boots Alliance and VillageMD announced that WBA has accelerated its investment in VillageMD to support the opening of 600 to 700 Village Medical at Walgreens primary care clinics in more than 30 U.S.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is pleased to report it has enrolled and safely dosed the last patient for stage 2 of Part C of its TACTI-002 Phase II study.

The strategic investment in Devicare complements Advanced MedTech’s product portfolio and strengthens its leadership in urology and kidney stone management

Harpoon Therapeutics, Inc., announced the pricing of an underwritten public offering of 5,882,352 shares of its common stock at a price to the public of $17.00 per share.